Learn about our comprehensive antibody validation methods to ensure monospecificity.  Antibody Validation>>

IL-2 Antibodies

Interleukin-2 (IL-2) has a molecular weight of approximately 15 kDa and is primarily produced by activated T cells, particularly CD4+ T helper cells and CD8+ cytotoxic T cells. It can also be produced by regulatory T cells (Tregs) and other immune cells. It is a key cytokine that plays a central role in regulating immune responses and also functions as a growth factor for T cells, promoting their proliferation and differentiation.

Interleukin-2 dysregulation is associated with autoimmune diseases like type 1 diabetes and multiple sclerosis, where aberrant immune responses can damage tissue. Additionally, deficiency or dysfunction of this cytokine may contribute to immunodeficiency, making individuals more susceptible to infections. IL-2 is also involved in the immune response to cancer, and therapeutic strategies involving it have been explored for cancer treatment.

Antibodies against IL-2 are used in research to study the expression and function of Interleukin-2 in various biological samples. These antibodies can be used in techniques like ELISA, western blotting, and flow cytometry to detect and quantify it. Clinical applications include its use as a therapeutic agent to boost the immune response against certain cancers, such as metastatic melanoma and renal cell carcinoma. In diagnostics, measuring IL-2 levels may be relevant in assessing immune function or identifying immune-related disorders.


Interleukin-2, T-cell growth factor, Aldesleukin; Involved in regulation of T cell clonal expansion; Lymphokine; POIL2; T-cell growth factor (TCGF)

Research Areas

Cardiovascular, Immunology, AKT Signaling, Cytokine Signaling, Hematopoietic Stem Cells, Signal Transduction, Transcription Factors

Showing all 13 results


Showing all 13 results


We hold Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.